Allred Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
1,327
+22
+2% +$22.5K 0.52% 49
2026
Q1
$1.2M Buy
1,305
+460
+54% +$466K 0.44% 53
2025
Q4
$909K Sell
845
-149
-15% -$142K 0.33% 72
2025
Q3
$759K Sell
994
-6
-0.6% -$4.46K 0.26% 87
2025
Q2
$780K Sell
1,000
-51
-5% -$39.6K 0.29% 79
2025
Q1
$868K Sell
1,051
-4
-0.4% -$3.33K 0.35% 71
2024
Q4
$814K Sell
1,055
-11
-1% -$9.11K 0.32% 73
2024
Q3
$944K Sell
1,066
-100
-9% -$89.9K 0.37% 62
2024
Q2
$1.06M Buy
1,166
+227
+24% +$182K 0.4% 51
2024
Q1
$731K Buy
939
+200
+27% +$142K 0.29% 81
2023
Q4
$431K Buy
+739
New +$431K 0.19% 111
2021
Q2
Sell
-311
Closed -$58.1K 507
2021
Q1
$58.1K Buy
+311
New +$60.8K 0.03% 356
2020
Q1
Sell
-87
Closed -$11.4K 447
2019
Q4
$11.4K Buy
+87
New +$10.1K 0.01% 569

Other funds holding LLY

Allred Capital Management's LLY Position: Q2 2026 in Review

Allred Capital Management increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $22.5K and bringing the position to 1,327 shares worth $1.59M. The position accounts for 0.52% of the portfolio, ranked #49.

Allred Capital Management first reported a position in LLY in Q4 2019 and has held it in 13 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Allred Capital Management held 1,327 shares of Eli Lilly worth $1.59M as of Q2 2026.
  • Allred Capital Management bought 22 Eli Lilly shares in Q2 2026, an estimated $22.5K.
  • Eli Lilly made up 0.52% of Allred Capital Management's portfolio in Q2 2026, its #49 holding.
  • Allred Capital Management first reported a position in Eli Lilly in Q4 2019 and has held it in 13 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Allred Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.